Associated Papers
Correlation of age of onset and clinical severity in Niemann-Pick disease type C1 with lysosomal abnormalities and gene expression.
Baxter LL et al.
Scientific Reports, 2022
Unbiased yeast screens identify cellular pathways affected in Niemann-Pick disease type C.
Colaco A et al.
Life Science Alliance, 2020
Mechanistic convergence and shared therapeutic targets in Niemann-Pick disease.
Colaco A et al.
Journal of Inherited Metabolic Disease, 2020
Individualized management of genetic diversity in Niemann-Pick C1 through modulation of the Hsp70 chaperone system.
Wang C et al.
Human Molecular Genetics, 2020
FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
Newton J et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2017
Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.
Pipalia NH et al.
Journal of Lipid Research, 2017
Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease.
Mazzacuva F et al.
Febs Letters, 2016
27139891 (PubMed )
Supplement: FEB2-590-1651-s001.pdf
Parkinsonism syndrome in heterozygotes for Niemann-Pick C1.
Kluenemann HH et al.
Journal of the Neurological Sciences, 2013
Elucidating the mutational impact in causing Niemann-Pick disease type C: an in silico approach.
Kannan P et al.
Journal of Biomolecular Structure & Dynamics, 0
36264126 (PubMed )
Supplement: supplement_1.docx
Select a paper to view details